2016 Volume 36 Issue 5 Pages 901-904
【Background】The aim of this study was to evaluate the outcome of emergent cholecystectomy in patients with acute cholecystitis on antithrombotic therapy (AT), and to determine the risk factors for intraoperative hemorrhage.【Patients and Methods】From January 2007 to August 2014, 257 patients underwent emergent cholecystectomy at our institution; out of these, 64 patients were receiving AT, while the remaining 193 patients were not. We evaluated the influence of AT on the intraoperative blood loss. 【Results】Only hospital stay was significant longer in the patient group on AT(P=0.030). The intraoperative blood loss and need for quantum of transfusion were not significantly different between the AT and non-AT groups. Multivariate analysis failed to identify AT as a significant risk factor for intraoperative blood loss of more than 50ml. None of the patients developed any hemorrhage or thrombotic complications.【Conclusion】Emergent cholecystectomy appears to be feasible in patients on AT.
